UCB3101
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for UCB3101, covering 2025-12-26 to 2025-12-26. Get the full timeline:
Most recent: Clinical Trial Update: A First-in-human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UCB3101 in Healthy Participants [Phase 1]